EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Autoimmunity following SARS-CoV-2 infection and vaccination: Systematic review and meta-analysis

Anouar Oudhini, Mourad Elghali, Youssef Zanina, Maha Changuel, Nabil Sakly

Clinical Immunology · 2026-06 · 285 · 110702

DOI: 10.1016/j.clim.2026.110702 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Immunology, 2026-06. Verfasst von Anouar Oudhini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of pharmacy, University of Monastir, Tunisia. Hauptthemen laut MEDLINE: COVID-19, Autoimmunity, SARS-CoV-2, Autoimmune Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: University of Tsukuba, University of Florida.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: To systematically review and meta-analyze the available evidence on the association between SARS-CoV-2 infection, COVID-19 vaccination, and the development of new autoimmune conditions (AIC). METHODS: This study followed the PRISMA guidelines. MEDLINE, Scopus, Cochrane Library, and Google Scholar were searched until December 31, 2024, for studies reporting new-onset autoimmunity after SARS-CoV-2 infection or vaccination. Meta-analyses using random-effects models calculated pooled odds ratios using RStudio 4.3. RESULTS: Of the 2544 records identified, 39 studies were included in the systematic review, and 17 studies were included in the meta-analysis. A significant association was found between SARS-CoV-2 infection and new AIC (p = 0.0054) and particularly type 1 diabetes (p = 0.0229), blistering diseases (p = 0.0452), systemic sclerosis (p = 0.0153), and vitiligo (p = 0.0122). Regarding SARS-CoV-2 vaccine-induced autoimmunity, no association between COVID-19 vaccines and new AIC was observed. CONCLUSION: This study provides evidence that SARS-CoV-2 infection may strongly induce autoimmunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19AutoimmunitySARS-CoV-2Autoimmune DiseasesVaccinationCOVID-19 VaccinesHumansDiabetes Mellitus, Type 1

Stichwörter der Autor:innen

Autoimmune diseasesAutoimmunityCOVID-19COVID-19 vaccinesInfectionSARS-CoV-2

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Faculty of pharmacy, University of Monastir, Tunisia.
  • Laboratory of Immunology, FB hospital of Monastir, University of Monastir, Tunisia. Electronic address: mouradghali3@gmail.com.
  • Laboratory of Immunology, FB hospital of Monastir, University of Monastir, Tunisia.
  • Laboratory of Immunology, FB hospital of Monastir, University of Monastir, Tunisia; Laboratory of Medical and Molecular Parasitology-Mycology (code: LR12ES08), Department of Clinical Biology B, Faculty of Pharmacy, Univ…

Förderung

  • University of Tsukuba
  • University of Florida

Zitieren

APA

Oudhini, A., Elghali, M., Zanina, Y., Changuel, M., & Sakly, N. (2026). Autoimmunity following SARS-CoV-2 infection and vaccination: Systematic review and meta-analysis. Clinical Immunology, 285, 110702. https://doi.org/10.1016/j.clim.2026.110702

Vancouver

Oudhini A, Elghali M, Zanina Y, Changuel M, Sakly N. Autoimmunity following SARS-CoV-2 infection and vaccination: Systematic review and meta-analysis. Clinical Immunology. 2026;285:110702. doi:10.1016/j.clim.2026.110702

BibTeX
@article{Oudhini2026,
  author = {Oudhini, Anouar and Elghali, Mourad and Zanina, Youssef and Changuel, Maha and Sakly, Nabil},
  title = {Autoimmunity following SARS-CoV-2 infection and vaccination: Systematic review and meta-analysis},
  journal = {Clinical Immunology},
  year = {2026},
  volume = {285},
  pages = {110702},
  doi = {10.1016/j.clim.2026.110702}
}
Kostenlos starten →